1 results match your criteria: "b Hospital Universitario Puerta de Hierro Majadahonda[Affiliation]"
Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group.
Leuk Lymphoma
June 2019
b Hospital Universitario Puerta de Hierro Majadahonda, Madrid , Spain.